primary
Everything filed under endpoints in our medical research coverage, the 6 reports filed on it so far.
Bristol Myers' admilparant shows dose-dependent efficacy in IPF trial
Bristol Myers Squibb's Phase 3 trial of admilparant for idiopathic pulmonary fibrosis met its primary endpoint only at the lower 60 mg dose, raising...
ArriVent's furmonertinib fails key lung cancer trial endpoint
ArriVent BioPharma's oral lung cancer drug furmonertinib failed to significantly delay tumor progression versus chemotherapy in a late-stage study...
Amgen's Sjögren's drug succeeds in first Phase 3 trial
Amgen's experimental drug dazodalibep met its primary goal in a Phase 3 study for Sjögren's syndrome, showing early and sustained symptom improvement.
AbbVie's dual-acting myeloma drug etentamig meets Phase 3 endpoint
AbbVie reported that its bispecific antibody etentamig met the primary endpoint in a Phase 3 trial for multiple myeloma.
Pharmalittle: Eyepoint Faces Setback, Amylyx Sees Win, and More
Eyepoint's experimental treatment for age-related blindness fails to meet primary goal, while Amylyx's Avexitide shows promise.
Eyepoint Study Results Disappoint for Vision Treatment
Eyepoint's experimental treatment for age-related blindness fails to meet primary goal in Phase 3 clinical trial.